MedPath

Alio WEAR Study: Long-term Wear of the Alio Platform

Not Applicable
Recruiting
Conditions
End Stage Kidney Disease
Registration Number
NCT06056739
Lead Sponsor
Alio, Inc.
Brief Summary

The WEAR study is long-term interventional study designed to evaluate patient and clinician use of the Alio platform, per its FDA cleared indications.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • At least 18 years of age.
  • Receiving hemodialysis via an AVF or AVG in an arm location at the time of study start.
  • Able to wear the SmartPatch effectively at the specified location on the arm.
  • Ability to understand and sign a written informed consent form, which must be obtained prior to initiation of any study procedures.
  • Willing and able to wear the SmartPatch as instructed and comply with all interviews, surveys and questionnaires, and schedule of evaluations.
Exclusion Criteria
  • Skin near the proximity of the AV access that is chronically swollen, infected, inflamed, open wounds, lesions, or has skin eruptions.
  • Participation in any other clinical trials involving investigational or marketed products that in the opinion of the investigator could affect the quality of the data.
  • Other conditions that in the opinion of the Principal Investigator may increase risk to the subject and/or compromise the quality of the clinical trial.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Assessing usage of the Alio platform by the test subjectUp to 1 year

Assessing compliance and ease of use via surveys

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Site 1

🇺🇸

Huntley, Illinois, United States

Site 1
🇺🇸Huntley, Illinois, United States
Stacey Miller
Contact
stacey@alio.ai

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.